Clinical utility of nivolumab in the treatment of advanced melanoma

Por Asmar, Ramsey, Yang, Jessica, Carvajal, Richard D
Publicado no Ther Clin Risk Manag (2016)

Ipilimumab in patients with melanoma and autoimmune disease

Por Kyi, Chrisann, Carvajal, Richard D, Wolchok, Jedd D, Postow, Michael A
Publicado em 2014

Study design and rationale for a randomised, placebo-controlled, double-blind study to assess the efficacy of selumetinib (AZD6244; ARRY-142886) in combination with dacarbazine in...

Por Carvajal, Richard D., Schwartz, Gary K., Mann, Helen, Smith, Ian, Nathan, Paul D.
Publicado no BMC Cancer (2015)

Dropped head syndrome: Report of three cases during treatment with a MEK inhibitor

Por Chen, Xi, Schwartz, Gary K., DeAngelis, Lisa M., Kaley, Thomas, Carvajal, Richard D.
Publicado em 2012

Definite regression of cutaneous melanoma metastases upon addition of topical contact sensitizer diphencyprone to immune checkpoint inhibitor treatment

Por Gulati, Nicholas, Carvajal, Richard D., Postow, Michael A., Wolchok, Jedd D., Krueger, James G.
Publicado no Exp Dermatol (2016)

Uveal melanoma: epidemiology, etiology, and treatment of primary disease

Por Krantz, Benjamin A, Dave, Nikita, Komatsubara, Kimberly M, Marr, Brian P, Carvajal, Richard D
Publicado no Clin Ophthalmol (2017)

Melanoma driver mutations and immune therapy

Por Johnson, Douglas B., Lovly, Christine M., Sullivan, Ryan J., Carvajal, Richard D., Sosman, Jeffrey A.
Publicado no Oncoimmunology (2016)

Metastatic disease from uveal melanoma: treatment options and future prospects

Por Carvajal, Richard D, Schwartz, Gary K, Tezel, Tongalp, Marr, Brian, Francis, Jasmine H, Nathan, Paul D
Publicado no Br J Ophthalmol (2017)

A Phase I Clinical Trial of Safingol in Combination with Cisplatin in Advanced Solid Tumors

Por Dickson, Mark A., Carvajal, Richard D., Merrill, Alfred H., Gonen, Mithat, Cane, Lauren M., Schwartz, Gary K.
Publicado em 2011

Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation

Por Morales, Rita E, Shoushtari, Alexander N, Walsh, Michelle M, Grewal, Priya, Lipson, Evan J, Carvajal, Richard D
Publicado no J Immunother Cancer (2015)

Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion and MEK-resistance.

Por Ambrosini, Grazia, Pratilas, Christine A., Qin, Li-Xuan, Tadi, Madhavi, Surriga, Oliver, Carvajal, Richard D., Schwartz, Gary K.
Publicado em 2012

Cutis Verticis Gyrata in Association With Vemurafenib and Whole-Brain Radiotherapy

Por Harding, James J., Barker, Christopher A., Carvajal, Richard D., Wolchok, Jedd D., Chapman, Paul B., Lacouture, Mario E.
Publicado no J Clin Oncol (2014)

Anal versus Rectal Melanoma: Does Site of Origin Predict Outcome?

Por Bello, Danielle M., Smyth, Elizabeth, Perez, Daniel, Khan, Shaheer, Temple, Larissa K., Ariyan, Charlotte E., Weiser, Martin R., Carvajal, Richard D.
Publicado em 2013

Combined immunotherapy and radiation for treatment of mucosal melanomas of the lower genital tract()

Por Schiavone, Maria B., Broach, Vance, Shoushtari, Alexander N., Carvajal, Richard D., Alektiar, Kaled, Kollmeier, Marisa A., Abu-Rustum, Nadeem R., Leitao, Mario M.
Publicado no Gynecol Oncol Rep (2016)

Clinical Activity of Ipilimumab in Acral Melanoma: A Retrospective Review

Por Johnson, Douglas B., Peng, Chengwei, Abramson, Richard G., Ye, Fei, Zhao, Shilin, Wolchok, Jedd D., Sosman, Jeffrey A., Carvajal, Richard D., Ariyan, Charlotte E.
Publicado no Oncologist (2015)

Predictors of early treatment discontinuation in patients enrolled on Phase I oncology trials

Por Hyman, David M., Eaton, Anne A., Gounder, Mrinal M., Pamer, Erika G., Pettiford, Jasmine, Carvajal, Richard D., Ivy, S. Percy, Iasonos, Alexia, Spriggs, David R.
Publicado no Oncotarget (2015)

Disease stabilization with pembrolizumab for metastatic acral melanoma in the setting of autoimmune bullous pemphigoid

Por Beck, Kristen M., Dong, Joanna, Geskin, Larisa J., Beltrani, Vincent P., Phelps, Richard G., Carvajal, Richard D., Schwartz, Gary, Saenger, Yvonne M., Gartrell, Robyn D.
Publicado no J Immunother Cancer (2016)

A Phase 2 Study of Flavopiridol (Alvocidib) in Combination with Docetaxel in Refractory, Metastatic Pancreatic Cancer (NCI#6366)

Por Carvajal, Richard D., Tse, Archie, Shah, Manish A., Lefkowitz, Robert A., Gonen, Mithat, Gilman-Rosen, Lisa, Kortmansky, Jeremy, Kelsen, David P., Schwartz, Gary K., O'Reilly, Eileen M.
Publicado em 2009

Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting

Por Ku, Geoffrey Y, Yuan, Jianda, Page, David B, Schroeder, Sebastian E A, Panageas, Katherine S, Carvajal, Richard D, Chapman, Paul B, Schwartz, Gary K, Allison, James P, Wolchok, Jedd D
Publicado em 2010

A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol

Por Dickson, Mark A., Shah, Manish A., Rathkopf, Dana, Tse, Archie, Carvajal, Richard D., Wu, Nian, Lefkowitz, Robert A., Gonen, Mithat, Cane, Lauren M., Dials, Heather J., Schwartz, Gary K.
Publicado em 2010